Syntara Ltd (ASX:SNT)
A$ 0.043 0.003 (7.5%) Market Cap: 54.93 Mil Enterprise Value: 51.64 Mil PE Ratio: 0 PB Ratio: 10.00 GF Score: 0/100

Pharmaxis Ltd Acquisdata Podcast with Gary Phillips on COVID-19 Impact and Response Transcript

Apr 29, 2020 / NTS GMT
Release Date Price: A$0.09
Fiona Fox
Acquisdata Inc. - Media

Well, Gary, it's been about six weeks, I think, since Australia locked down in response to the COVID-19 outbreaks which had been declared a public health emergency of international concern by the WHO on January 30, it was, and characterized as a pandemic on the March 11.

Questions & Answers

Fiona Fox
Acquisdata Inc. - Media

So what impact, Gary, has the virus and the response to it had on Pharmaxis's operations and its current products and also its product in the pipeline?

Gary Phillips
Pharmaxis Ltd - CEO

So I suppose the initial thought when we first realized that there was going to be having to work from home and social distancing, our first thought was for the patients in Europe, the US, Russia, and some parts of Asia that are currently taking products that are manufactured in our factory at Frenchs Forest.

So clearly, the first thing was, how do we protect the workers there to ensure that they can carry on with the production. And then, was the ongoing impact

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot